• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

EVOTEC SE INH O.N. (EVT)

Inhaber-Aktien o.N.
Sell: €5.50|Buy: €5.58|Change: 0 (0.45%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Address

Manfred Eigen Campus
Essener Bogen 7
Hamburg
DEU
22419

Telephone

+49 040 56081286

Website

https://www.evotec.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Evotec SE Fourth Quarter Earnings Conference Call for 20262027-04-08T08:00:00
Evotec SE Fourth Quarter Earnings Results for 20262027-04-08T00:00:00
Evotec SE Annual Report for 20262027-04-08T00:00:00
Evotec SE Third Quarter Earnings Conference Call for 20262026-11-05T08:00:00
Evotec SE Third Quarter Earnings Results for 20262026-11-05T00:00:00
Evotec SE Second Quarter Earnings Conference Call for 20262026-08-13T08:00:00
Evotec SE Second Quarter Earnings Results for 20262026-08-13T00:00:00
Evotec SE Annual General Meeting for 20262026-06-03T10:00:00
Evotec SE First Quarter Earnings Conference Call for 20262026-05-06T14:00:00
Evotec SE First Quarter Earnings Results for 20262026-05-06T00:00:00
Evotec SE Fourth Quarter Earnings Conference Call for 20252026-04-08T08:00:00
Evotec SE Fourth Quarter Earnings Result for 20252026-04-08T00:00:00
Evotec SE Annual Report for 20252026-04-08T00:00:00

Previous key dates

NameKey Date
Evotec SE Fourth Quarter Earnings Conference Call for 20252026-04-08T08:00:00
Evotec SE Fourth Quarter Earnings Result for 20252026-04-08T00:00:00
Evotec SE Annual Report for 20252026-04-08T00:00:00
Evotec SE Third Quarter Earnings Conference Call for 20252025-11-05T08:00:00
Evotec SE Third Quarter Earnings Result for 20252025-11-05T00:00:00
Evotec SE Second Quarter Earnings Conference Call for 20252025-08-13T08:00:00
Evotec SE Second Quarter Earnings Result for 20252025-08-13T00:00:00
Evotec SE Annual General Meeting for 20252025-06-03T10:00:00
Evotec SE First Quarter Earnings Conference Call for 20252025-05-06T14:00:00
Evotec SE First Quarter Earnings Result for 20252025-05-06T00:00:00
Evotec SE Fourth Quarter Earnings Conference Call for 20242025-04-17T08:00:00
Evotec SE Fourth Quarter Earnings Result for 20242025-04-17T00:00:00
Evotec SE Annual Report for 20242025-04-16T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.